Anderman Toddinsider trades

In SEC Form 4 filings, Anderman Todd is listed as Chief Legal Officer of Ocular Therapeutix, Inc (OCUL). In the last 90 days, Anderman Todd sold $87.4K of Ocular Therapeutix, Inc (OCUL) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
OCULOcular Therapeutix, Inc	Chief Legal Officer	1	Oct 13

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-13

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
OCULOcular Therapeutix, Inc	Oct 8	Oct 13	S	11,984	$7.29	Sale −$87,363	140,484	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.